TrialAnnals of the rheumatic diseases2018

Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate.

Hiroaki Matsuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.